# A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure

> **NCT00439868** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 33 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** WellbutrinXL
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00439868
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-16
- **Primary completion:** 2007-06-08
- **Final completion:** 2007-06-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439868, "A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00439868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*